Anebulo Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:ANEB) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

Nouvelles

Le titre de l’action Anebulo Pharmaceuticals chute après l’annonce de son retrait du Nasdaq

Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans

Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC

Anebulo completes oversubscribed share repurchase tender offer

Le titre d’Anebulo Pharmaceuticals s’effondre après l’abandon du projet de regroupement d’actions

Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan

Anebulo shifts from reverse stock split to tender offer in go-private plan

Crude Oil Jumps 2%; Chicago Fed National Activity Index Improves Slightly In September - Adeia (NASDAQ:ADEA), Anebulo Pharmaceuticals (NASDAQ:ANEB)

US Stocks Higher; Nasdaq Surges Over 100 Points - Anebulo Pharmaceuticals (NASDAQ:ANEB), EUDA Health Holdings (NASDAQ:EUDA)

Anebulo commence un essai clinique de phase 1 pour un traitement de toxicité au cannabis par voie intraveineuse

Anebulo begins phase 1 trial of IV cannabis toxicity treatment

Anebulo Pharmaceuticals examine ses alternatives stratégiques dans le cadre d’un projet de privatisation